Insider Trading activities of Praecis Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Praecis Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Praecis Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Praecis Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is PRCS. The reporting company's CIK number is 1033025.
The total value of stock buying since 2005 is $22,125.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $167,846.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Praecis Pharmaceuticals Inc (PRCS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2006-09 0 $0 0 $0 24,200 $32,186
2006-07 0 $0 0 $0 92,500 $123,025
2006-03 0 $0 0 $0 9,500 $12,635
2005-03 15,000 $22,125 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Praecis Pharmaceuticals Inc insiders (PRCS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2006-09-01 Mclaughlin Kevin F (President and CEO) Option Ex 24,200 1.33 32,186
2006-07-10 Gefter Malcolm L Phd (Chairman and CSO) Option Ex 92,500 1.33 123,025
2006-03-13 Gefter Malcolm L Phd (Director) Option Ex 9,500 1.33 12,635
2005-03-07 Keavany Michael J (Marketing) Buy 15,000 1.48 22,125

Insider trading activities including stock purchases, stock sales, and option exercises of PRCS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Praecis Pharmaceuticals Inc (symbol PRCS, CIK number 1033025) see the Securities and Exchange Commission (SEC) website.